Lum D F, Welton M L
Division of Gastroenterology, University of California Davis Medical Center, Sacramento, USA.
Surg Oncol Clin N Am. 1996 Jul;5(3):621-32.
In the past several years, there have been major advances in the understanding of colorectal cancer from both the clinical and basic science level. Although there are various techniques for colorectal cancer screening and surveillance, the most cost-effective approach has yet to be determined. As molecular biology techniques are improved and incorporated into clinical practice, identification of high-risk populations seems possible. With future advances in endoscopy and imaging, patient compliance can be improved. With the proper combination of both clinical and basic science techniques, it seems reasonable that a further reduction in the mortality from colorectal cancer can be accomplished.
在过去几年中，无论是从临床还是基础科学层面，对结直肠癌的认识都取得了重大进展。尽管有多种结直肠癌筛查和监测技术，但最具成本效益的方法尚未确定。随着分子生物学技术的改进并应用于临床实践，识别高危人群似乎成为可能。随着未来内镜检查和影像学的进步，患者的依从性可以得到提高。通过临床和基础科学技术的适当结合，进一步降低结直肠癌死亡率似乎是合理的。
